Association between MTHFD1 polymorphisms and neural tube defect susceptibility
Jingjing Meng1, Lei Han2, Bo Zhuang3
1Neonatal Ward, Jining No. 1 People's Hospital, Jining 272011, China.
Journal of the Neurological Sciences
|December 20, 2014
Summary
Neural tube defect (NTD) risk is linked to MTHFD1 gene variants in Chinese neonates. The 1958G>A polymorphism, particularly the AA genotype, increases NTD susceptibility.
Area of Science:
- Genetics
- Neonatal Health
- Folate Metabolism
Background:
- Neural tube defects (NTDs) are common congenital anomalies with complex origins.
- Periconceptional folic acid is hypothesized to prevent NTD risk.
- The MTHFD1 gene plays a crucial role in folate metabolism and is associated with NTD risk.
Purpose of the Study:
- To investigate the association between MTHFD1 gene polymorphisms and NTD susceptibility.
- To evaluate three specific single-nucleotide polymorphisms (SNPs) in the MTHFD1 gene: 401A>G, 2305C>T, and 1958G>A.
Main Methods:
- A case-control study involving 222 neonates (122 with NTD, 100 healthy controls).
- Genotyping of MTHFD1 SNPs (401A>G, 2305C>T, 1958G>A) using the SNapShot method.
- Statistical analysis including Mann-Whitney test, ANOVA, chi-square test, and a meta-analysis for the 1958G>A variant.
Main Results:
- The MTHFD1 1958G>A polymorphism (specifically the AA genotype) showed a significant association with increased NTD risk in the studied population.
- No statistically significant association was found for the 401A>G and 2305C>T SNPs with NTD risk.
- A meta-analysis suggested that the 1958G>A variant may not be a genetic risk factor in the Caucasian population.
Conclusions:
- The MTHFD1 1958G>A polymorphism is significantly associated with NTD susceptibility in the Chinese population.
- AA homozygote carriers of the 1958G>A variant have a higher likelihood of developing NTD.
- Further research is required to validate the risk effect and functional impact of this MTHFD1 polymorphism.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
135
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
135
Translation
162.8K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
162.8K
Translation
23.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
23.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
74
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
74
Neurulation
47.8K
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.8K
Genetic Lingo
119.2K
Overview
119.2K


